Siro Clinpharm Pvt. is a prominent clinical research organisation headquartered in India, with a strong operational presence across various regions. Established in 2005, the company has made significant strides in the pharmaceutical and biotechnology sectors, specialising in clinical trial management, regulatory affairs, and data management services. Siro Clinpharm is recognised for its commitment to quality and innovation, offering tailored solutions that enhance the efficiency of clinical development processes. With a diverse portfolio of services, the company has positioned itself as a trusted partner for global pharmaceutical companies, contributing to numerous successful drug approvals. Notable achievements include a robust track record in conducting trials across multiple therapeutic areas, solidifying Siro Clinpharm's reputation as a leader in the clinical research industry.
How does Siro Clinpharm Pvt's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Siro Clinpharm Pvt's score of 14 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Siro Clinpharm Pvt, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Siro Clinpharm may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it will be essential for Siro Clinpharm to consider developing and communicating its climate commitments to align with global standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Siro Clinpharm Pvt has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
